About Us

ADA Newsroom

Get the latest news from ADA, including press releases and research announcements.

Senior couple reading news on laptop

Press Releases

If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.

Recent Press release

American Diabetes Association logo reversed out white on red background
Advocacy News

The American Diabetes Association Applauds Illinois Governor for Approving Legislation Expanding Access to CGMs for Medicaid Beneficiaries   

The American Diabetes Association® (ADA) applauds…
ADA_SS24_NewsroomImage
Press release

One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol

Largest-Study-of-its-Kind Uncovers Potential Underlying
ADA_SS24_NewsroomImage
Press release

Common Type 2 Diabetes Drug Shown to Safely Reduce the Progression of Kidney Disease in Adolescents with Type 1 Diabetes

SGLT2i Shown as Potential Solution to Help Manage Renal

Official Statement

Recent Press release

American Diabetes Association logo reversed out white on red background
Advocacy News

The American Diabetes Association Applauds Illinois Governor for Approving Legislation Expanding Access to CGMs for Medicaid Beneficiaries   

The American Diabetes Association® (ADA) applauds…
ADA_SS24_NewsroomImage
Press release

One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol

Largest-Study-of-its-Kind Uncovers Potential Underlying
ADA_SS24_NewsroomImage
Press release

Common Type 2 Diabetes Drug Shown to Safely Reduce the Progression of Kidney Disease in Adolescents with Type 1 Diabetes

SGLT2i Shown as Potential Solution to Help Manage Renal
Filter by:
Sort by:
Press release

Early Use of Sotagliflozin Provides Benefits for People With Type 2 Diabetes With Chronic Kidney Disease or Heart Failure

Update on SCORED and SOLOIST trials shows reduction in cardiovascular events and stroke using glucose-lowering agents Results from two…
Published: Tuesday, June 29, 2021
ada-a_comms_logo
Press release

Latest Data From SURPASS Trials Demonstrate Tirzepatide Provided Meaningful Blood Sugar Reductions

Results from four clinical studies identify potential new treatment option for people with type 2 diabetes Data from the SURPASS global
Published: Tuesday, June 29, 2021
ada-a_comms_logo
Press release

Liraglutide and Insulin More Effective in Maintaining Average Blood Glucose Levels Than Other Common Diabetes Drugs

Head-to-head comparison of glucose-lowering medications helps inform individualized treatment strategies Today, investigators sponsored…
Published: Monday, June 28, 2021
ada-a_comms_logo

Meet Our Experts

The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.

CEO Charles
Charles D. Henderson

Chief Executive Officer

Robert Gabbay
Robert Gabbay, MD, PhD

Chief Scientific and Medical Officer 

Lisa Murdock headshot
Lisa Murdock

Chief Advocacy Officer 

Dr. El Sayed
Nuha El Sayed, MD, MMSc

Senior Vice President, Health Care Improvement 

Marlon Pragnell
Marlon Pragnell, PhD

Vice President, Research & Science 

Crystal Woodward
Crystal Woodward, MPS

Managing Director, Legal Advocacy/Safe at School